FMR LLC

Holdings History for Olema Pharmaceuticals, Inc. - COMMON STOCK (OLMA)

Symbol: OLMA on Nasdaq
Investment type: Equity / COMMON STOCK
Latest Disclosed Shares Owned: 9,998,060 shares
Security Ownership %: 12%

Shares, Excluding Options vs Price

Value, Excluding Options

FMR LLC ownership in Olema Pharmaceuticals, Inc. COMMON STOCK (OLMA)

06 Mar 2026 - FMR LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 9,998,060 shares of Olema Pharmaceuticals, Inc. COMMON STOCK (OLMA). This represents 12% ownership of the company. In their previous filing dated 05 Feb 2026, FMR LLC had reported owning 5,023,092 shares, indicating an increase of +99%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
FMR LLC	12%	+103%	$250,051,474	9,998,060	+4,974,967	+99%	$25.01	13G/A	27 Feb 2026	06 Mar 2026, 10:05
FMR LLC	6.3%		$125,577,309	5,023,092			$25.00	13G	31 Dec 2025	05 Feb 2026, 13:31

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.01%	+0.01%	$125,577,309	5,023,092	+4,993,670	+16973%	$25.00	Q4 2025
30 Sep 2025	0%	+0%	$288,045	29,422	+1,181	+4.2%	$9.79	Q3 2025
30 Jun 2025	0%	+0%	$120,307	28,241	+26,426	+1456%	$4.26	Q2 2025
31 Mar 2025	0%	-0%	$6,824	1,815	-44,013		$3.76	Q1 2025
31 Dec 2024	0%	+0%	$267,177	45,828	+43,927	+2311%	$5.83	Q4 2024
30 Sep 2024	0%	+0%	$22,698	1,901	+865	+83%	$11.94	Q3 2024
30 Jun 2024	0%	0%	$11,210	1,036	+40	+4%	$10.82	Q2 2024
31 Mar 2024	0%	0%	$11,275	996	+88	+9.7%	$11.32	Q1 2024
31 Dec 2023	0%	-0%	$12,739	908	-728	-44%	$14.03	Q4 2023
30 Sep 2023	0%	+0%	$20,205	1,636	+972	+146%	$12.35	Q3 2023
30 Jun 2023	0%	0%	$5,996	664	-8	-1.2%	$9.03	Q2 2023
31 Mar 2023	0%	0%	$2,332	672	-24	-3.4%	$3.47	Q1 2023
31 Dec 2022	0%	0%	$1,706	696	+342	+97%	$2.45	Q4 2022
30 Sep 2022	0%	-0%	$1,000	354	-3,569	-91%	$2.82	Q3 2022
30 Jun 2022	0%	-0%	$16,000	3,923	-104,722	-96%	$4.08	Q2 2022
31 Mar 2022	0%	-0%	$463,000	108,645	-454,209	-81%	$4.26	Q1 2022
31 Dec 2021	0%	-0%	$5,268,000	562,854	-44,197	-7.3%	$9.36	Q4 2021
30 Sep 2021	0%	-0%	$16,730,000	607,051	-35,700	-5.6%	$27.56	Q3 2021
30 Jun 2021	0%	-0%	$17,984,000	642,751	-9,946	-1.5%	$27.98	Q2 2021
31 Mar 2021	0%	-0%	$21,656,000	652,697	-1,800	-0.28%	$33.18	Q1 2021
31 Dec 2020	0%	+0%	$31,468,000	654,497	+654,497	NEW	$48.08	Q4 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.